The Next Wave for Virus Testing Stocks (NASDAQ: HOLX) (OTC US: ALST) (NASDAQ: FLGT)

While vaccines are rolling out rapidly around the developed world, and uptake is expected to produce some version of herd immunity within the next six months, scientists are acclimating to the idea that we may be locked in a long-term battle with Covid-19 that could last years or even decades. While the pandemic health crisis may recede from the front page during most of that battle, organizations, cities, states, countries, and major institutions will have to maintain a constant vigil and act...

read more

Stocks for the Pandemic Long Haul (NASDAQ: FLGT) (OTC US: ALST) (NASDAQ: HOLX)

Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many years to come, with a constant need for PPE, testing, vaccine rejiggering, specialized air filtration solutions, and other ‘coping’ tools and resources. Of all of these concepts, aside from vaccines, the most important may end up being rapid testing solutions. With that in mind, we take a look at a few of the...

read more

The Big Picture for Virus Testing Stocks (NASDAQ: FLGT) (OTC US: ALST) (NASDAQ: CODX)

The good news is that the end of the pandemic is in sight. The bad news is that it may never really be over. Even after we achieve the big goal of vaccine-induced herd immunity in the developed world, the pandemic will fester and mutate and hide out in the emerging world, continuously threatening from the shadows. While we appear on the verge of knocking out the scary version of this story – all but eradicating fatalities and hospitalizations where vaccines are widely available – the path will...

read more

The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)

The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus vaccine candidate, noting that it registered a 90% efficacy rate with no complications in its phase 3 study involving over 43K patients. Stocks took flight, bonds dropped, and small-caps and cyclicals massively outperformed tech stocks as the prospect of a reopening of the economy surged through the cyclical side of the market. However, as we are learning, the...

read more

The Second Wave Pandemic Portfolio (NASDAQ: LAKE) (NYSEAMERICAN: APT) (OTC: ALST) (NASDAQ: FLGT)

The pandemic is raging once again, with new record levels in case numbers across the US and EU. The spike is striking and proves the point for those who warned that cooler temperatures would mean a resurgence. The surge we have seen over the past week has set new records in many regions in terms of case numbers, with hospitalizations rapidly on the rise. With a vaccine still likely months away, PPE is the odds-on winner once again, along with social distancing and limited public gatherings....

read more

Covid Testing Stocks for the Win (NASDAQ: FLGT) (OTC: ALST) (NYSE: DGX)

With the cold and flu season rapidly approaching, and two recent viral vaccine candidates for COVID-19 just put on pause, the global health system and the world economy both hang in the balance. And the X-Factor that will determine a great deal about how we come through this process is “Testing”. New data from the NY Times yesterday states that new coronavirus cases are trending upward in 39 states, pushing the U.S. curve to its highest level since August. Testing – pervasively available,...

read more


Mcap MediaWire - Costumer Service

Translate »